Kaichun Wu

Active 1989–2026

269
Papers
29,558
Citations
103
h-index
245
i10-index

Citations

Citations per year for Kaichun Wu1989: 1 citations1990: 4 citations1991: 7 citations1992: 14 citations1993: 9 citations1994: 9 citations1995: 15 citations1996: 9 citations1997: 10 citations1998: 12 citations1999: 4 citations2000: 9 citations2002: 4 citations2003: 4 citations2004: 5 citations2005: 1 citations2006: 6 citations2007: 7 citations2008: 8 citations2009: 30 citations2010: 48 citations2011: 103 citations2012: 172 citations2013: 199 citations2014: 237 citations2015: 290 citations2016: 247 citations2017: 271 citations2018: 250 citations2019: 1,028 citations2020: 1,362 citations2021: 1,859 citations2022: 1,645 citations2023: 975 citations2024: 1,525 citations2025: 854 citations2026: 22 citations2001: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 4,253 citing papers, 27.9% of this breakdownUnited States: 2,837 citing papers, 18.6% of this breakdownUnited Kingdom: 627 citing papers, 4.1% of this breakdownItaly: 537 citing papers, 3.5% of this breakdownGermany: 494 citing papers, 3.2% of this breakdownCanada: 438 citing papers, 2.9% of this breakdownJapan: 400 citing papers, 2.6% of this breakdownIndia: 363 citing papers, 2.4% of this breakdownSouth Korea: 343 citing papers, 2.3% of this breakdownFrance: 338 citing papers, 2.2% of this breakdownSpain: 324 citing papers, 2.1% of this breakdownAustralia: 312 citing papers, 2.1% of this breakdown
0%27.9%Other 26.1%

Fields

  • Medicine45.8%
  • Biochemistry, Genetics and Molecular Biology44.8%
  • Immunology and Microbiology4.1%
  • Neuroscience1.5%
  • Agricultural and Biological Sciences0.7%
  • Nursing0.6%
  • Other2.5%

Topics

  • SARS-CoV-2 and COVID-19 Research5.6%
  • MicroRNA in disease regulation4%
  • Cancer-related molecular mechanisms research3.5%
  • Inflammatory Bowel Disease3.4%
  • Gut microbiota and health3.1%
  • Circular RNAs in diseases2.8%
  • Other77.6%

Coauthors

All papers

Open in search
  1. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emily Phung, Lauren A. Chang, Rebecca J. Loomis, Nedim Emil Altaras, Elisabeth Narayanan, Mihir Metkar, Vladimir Presnyak, Cuiping Liu, Mark K. Louder, Wei Shi, Kwanyee Leung, Eun Sung Yang, Ande West, Kendra L. Gully, Laura J. Stevens, Nianshuang Wang, Daniel Wrapp, Nicole A. Doria‐Rose, Guillaume Stewart-Jones, Hamilton Bennett, Gabriela Alvarado, Martha Nason, Tracy J. Ruckwardt, Jason S. McLellan, Mark R. Denison, James D. Chappell, Ian N. Moore, Kaitlyn M. Morabito, John R. Mascola, Ralph S. Baric, Andrea Carfı́, Barney S. Graham - Nature 2020 cited by 1,687

  2. Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8+ T cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2024 cited by 217

  3. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice

    Authors: , , , , , , , , , , , , - Journal of Hepatology 2017 cited by 415

  4. CD177+ neutrophils as functionally activated neutrophils negatively regulate IBD

    Authors: , , , , , , , , , , - Gut 2017 cited by 274

  5. GPCR activation and GRK2 assembly by a biased intracellular agonist

    Authors: , , , , , , , , , , , , , , , , , , - Nature 2023 cited by 121

  6. Incidence and Phenotype of Inflammatory Bowel Disease Based on Results From the Asia-Pacific Crohn's and Colitis Epidemiology Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Qin Ouyang, Zhirong Zeng, Zhenhua Zhu, Min Hu Chen, Pin Jin Hu, Kaichun Wu, Xin Wang, Marcellus Simadibrata, Murdani Abdullah, Justin CY Wu, Joseph J.�Y. Sung, Francis K.L. Chan - Gastroenterology 2013 cited by 840

  7. Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 cited by 182

  8. Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jack Greenhouse, Swagata Kar, Laurent Pessaint, Maciel Porto, Katelyn Steingrebe, Daniel Valentin, Serge Zouantcha, Kevin W. Bock, Mahnaz Minai, Bianca M. Nagata, Renee van de Wetering, Seyhan Boyoglu-Barnum, Kwanyee Leung, Wei Shi, Eun Sung Yang, Yi Zhang, John-Paul Todd, Lingshu Wang, Gabriela Alvarado, Hanné Andersen, Kathryn E. Foulds, Darin K. Edwards, John R. Mascola, Ian N. Moore, Mark G. Lewis, Andrea Carfı́, David C. Montefiori, Mehul S. Suthar, Adrian B. McDermott, Mario Roederer, Nancy J. Sullivan, Daniel C. Douek, Barney S. Graham, Robert A. Seder - Science 2021 cited by 329

  9. Chinese Consensus Report on Family-BasedHelicobacter pyloriInfection Control and Management (2021 Edition)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fen Wang, Huahong Wang, Jiangbin Wang, Jingtong Wang, Junping Wang, Xuehong Wang, Kaichun Wu, Xingzhou Xia, Wei‐Fen Xie, Yong Xie, Jian-Ming Xu, Changqing Yang, Guibin Yang, Yuan Yuan, Zhirong Zeng, Bingyong Zhang, Guiying Zhang, Guoxin Zhang, Jianzhong Zhang, Zhenyu Zhang, Pengyuan Zheng, Yin Zhu, Xiuli Zuo, Li-Ya Zhou, Nonghua Lyu, Yunsheng Yang, Zhaoshen Li - Gut 2021 cited by 183

  10. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Murdani Abdullah, Steve Tsang, Tai Chiu Wong, Aric J. Hui, Chung Mo Chow, Hon Ho Yu, Mo Fong Li, Ka Kei Ng, Jessica Ching, Justin CY Wu, Francis K.L. Chan, Joseph J.�Y. Sung - Gut 2014 cited by 444

  11. Tumor microbiome contributes to an aggressive phenotype in the basal-like subtype of pancreatic cancer

    Authors: , , , , , , , , , , , , , - Communications Biology 2021 cited by 143

  12. Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2022 cited by 303

  13. Microbiota transplantation: concept, methodology and strategy for its modernization

    Authors: , , , , , , - Protein & Cell 2018 cited by 300

  14. MicroRNA-31 Reduces Inflammatory Signaling and Promotes Regeneration in Colon Epithelium, and Delivery of Mimics in Microspheres Reduces Colitis in Mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zhengquan Yu - Gastroenterology 2019 cited by 220

  15. TGF-β1-Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis Through Transcriptionally Upregulating PD-L1 and CXCL12

    Authors: , , , , , , , , , , , , - Gastroenterology 2024 cited by 104

  16. Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2021 cited by 449

  17. Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside

    Authors: , , , , , , , , , , - Experimental Hematology and Oncology 2024 cited by 91

  18. Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine

    Authors: , , , , , , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2024 cited by 78

  19. Evolution of myeloid-mediated immunotherapy resistance in prostate cancer

    Authors: , , , , , , , , , , , , , , , , - Nature 2024 cited by 143

  20. Safety and Immunogenicity of XBB.1.5-Containing mRNA Vaccines

    Authors: , , , , , , , , , , , , , , , , , - medRxiv 2023 cited by 79

  21. Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties

    Authors: , , , , , , , , , , , , , , , , , - Cancer Cell 2019 cited by 169

  22. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel Valentin, Anthony Cook, Alan Dodson, Katelyn Steingrebe, Saule Nurmukhambetova, Sucheta Godbole, Amy R. Henry, Farida Laboune, Jesmine Roberts-Torres, Cynthia G. Lorang, Shivani Amin, Jessica F. Trost, Mursal Naisan, Manjula Basappa, Jacquelyn Willis, Lingshu Wang, Wei Shi, Nicole A. Doria‐Rose, Yi Zhang, Eun Sung Yang, Kwanyee Leung, Sijy O’Dell, Stephen D. Schmidt, Adam S. Olia, Cuiping Liu, Darcy R. Harris, Gwo‐Yu Chuang, Guillaume B. E. Stewart-Jones, Isabella Renzi, Yen‐Ting Lai, Agata Malinowski, Kaichun Wu, John R. Mascola, Andrea Carfı́, Peter D. Kwong, Darin K. Edwards, Mark G. Lewis, Hanné Andersen, Kizzmekia S. Corbett, Martha Nason, Adrian B. McDermott, Mehul S. Suthar, Ian N. Moore, Mario Roederer, Nancy J. Sullivan, Daniel C. Douek, Robert A. Seder - Cell 2022 cited by 228

  23. Conserved class B GPCR activation by a biased intracellular agonist

    Authors: , , , , , , , , , , , , - Nature 2023 cited by 56

  24. Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 cited by 257